Pregnancy’s impact on RA and SpA disease activity Reveals Key Risk Factors for Relapse
A groundbreaking French multicenter study shed new light on how pregnancy affects disease activity in
Recommended Posts
Read More »
Novel mPGES-1 inhibitor, vipoglanstat, shows no benefit for systemic sclerosis-related Raynaud’s phenomenon in clinical trial
A Phase 2 trial exploring the novel microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor vipoglanstat in patients with
IL-18 emerges as a potential biomarker and therapeutic target in primary Sjögren’s Syndrome
A new systematic review and meta-analysis published in Medicine has highlighted the significant elevation of
Expert Talk: Place of Iguratimod in RA
https://www.youtube.com/watch?v=v2TLeM5h0_w Disclaimer: The information in this educational activity is provided for general medical education purposes
Methylprednisolone fails to show benefit in very early systemic sclerosis: ‘Hit Hard and Early’ trial results
The ‘Hit Hard and Early’ randomized controlled trial published to investigate the efficacy of methylprednisolone
Otilimab demonstrates promising long-term safety profile in RA treatment
The long-term extension trial, contRAst X, published in BMJ Open, showed promising results regarding the
Quiz Corner
Quiz for MRI in Rheumatology
February 5, 2022
First Round quiz on Scleritis
February 3, 2022
Quiz for Dry Eye and Rheumatology
January 21, 2022
Raynaud’s Phenomenon Quiz
January 20, 2022
Immunology and Inflammation
[Day-2]Virtual Bi-Monthly Lecture series – 5 on Immunology and Inflammation
Dr. Sampath Rangasamy spoke about the role of inflammation in microvascular diabetic complications.
February 7, 2022
No Comments
[Day-1]Virtual Bi-Monthly Lecture series – 5 on Immunology and Inflammation
Dr. K. Gokulakrishnan discussed the adipose tissue and brain – The neuroinflammatory link. Neuroinflammation
February 7, 2022
No Comments
Immune-Mechanism of Autoimmune related Inflammatory Diseases of Skin
Dr. Chandrashekara. S discussed the Immune-Mechanism of Autoimmune related Inflammatory Diseases of Skin. Skin
January 1, 2022
No Comments
Auto-immune mediated Inflammatory Skin Disorder – Introduction to Clinical Variety
Autoimmune-mediated inflammatory skin disorder- introduction to clinical variety was discussed by Dr. Shekhar Neema.
January 1, 2022
No Comments
[Day-2] Lecture Series 4 (Autoimmunity and Inflammation)
Dr. Jyotirmay Biswas spoke about autoimmune uveitis and scleritis. 50% and 90% of uveitis and
November 17, 2021
No Comments
Eye and Rheumatology Series
Eye and Rheumatology Series – 4 : Anterior Uveitis
Dr. Padmamalini discussed the clinical clues in the differential diagnosis of anterior uveitis.
March 3, 2022
No Comments
Eye and Rheumatology Series – Episcleritis and Scleritis
Clinical evaluation of episcleritis & scleritis and interpretation of the differential diagnosis of episcleritis
February 1, 2022
No Comments
Eye and Rheumatology Series: Dry Eye Conditions
Dr. Prarthana Bhandary spoke about the ophthalmological perspective of dry eye differential diagnosis and
January 13, 2022
No Comments
Eye and Rheumatology Series : Ocular Surface Inflammation
Dr. Shilpa discussed briefly ocular surface inflammation including the different conditions i.e., Dry eye disease,
December 31, 2021
No Comments
Eye and Rheumatology Series – Interactive session
Rheumatology and Ophthalmology interactive series Inflammatory disease of the eye- Introduction Ocular surface inflammation- introduction
December 10, 2021
No Comments
Investigation in Rheumatology
February 7, 2022
No Comments
January 13, 2022
No Comments
